F-star’s (FSTX) Delayed Acquisition Presents A Risky Opportunity

filadendron/E+ via Getty Images

F-star Therapeutics (NASDAQ:FSTX) is a microcap company with macrocap dreams and a takeover bid at $7.12 per share. The company currently trades at $5.86. The gap remains on concern that although the UK govt has approved the deal, the

FSTX pipeline

FSTX pipeline (FSTX website)

FSTX technology

FSTX technology (FSTX website)

FS118 Development plan

FS118 Development plan (FSTX website)

Leave a Comment